222 related articles for article (PubMed ID: 15058251)
21. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in patients with metabolic syndrome.
Ragab A; Abousamra NK; Higazy A; Saleh O
Lab Hematol; 2008; 14(1):1-6. PubMed ID: 18403313
[TBL] [Abstract][Full Text] [Related]
22. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.
Aillaud MF; Pignol F; Alessi MC; Harle JR; Escande M; Mongin M; Juhan-Vague I
Thromb Haemost; 1986 Jun; 55(3):330-2. PubMed ID: 3092390
[TBL] [Abstract][Full Text] [Related]
23. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.
Meyer AA; Kundt G; Steiner M; Schuff-Werner P; Kienast W
Pediatrics; 2006 May; 117(5):1560-7. PubMed ID: 16651309
[TBL] [Abstract][Full Text] [Related]
24. Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2005 Feb; 15(1):26-30. PubMed ID: 15831157
[TBL] [Abstract][Full Text] [Related]
25. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
Niemir ZI; Kubiak A; Olejniczak P; Nowak A; Czekalski S
Rocz Akad Med Bialymst; 2004; 49():213-8. PubMed ID: 15631346
[TBL] [Abstract][Full Text] [Related]
26. Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6.
Newby DE; Stewart A; Witherow FN; Grieve S; Dawson P; Fox KA; Webb DJ; Ludlam CA
Thromb Haemost; 2000 Aug; 84(2):195-203. PubMed ID: 10959689
[TBL] [Abstract][Full Text] [Related]
27. [Endothelial parameters in blood plasma of patients suffering from ischaemic heart disease and undergoing surgery with extracorporeal circulation].
Rość D; Ogorzeja W; Kotschy M; Missima M; Jurkowski P
Pol Arch Med Wewn; 2004 Nov; 112(5):1297-302. PubMed ID: 15773511
[TBL] [Abstract][Full Text] [Related]
28. [Effect of severe multiple trauma complicated by acute lung injury on endothelial cell activity].
Siemiatkowski A; Kłoczko J; Wereszczyńska-Siemiatkowska U; Czaban SL
Przegl Lek; 2001; 58(7-8):767-71. PubMed ID: 11769384
[TBL] [Abstract][Full Text] [Related]
29. [Von Willebrand factor in plasma of patients with age related macular degeneration].
Malukiewicz-Wiśniewska G; Rość D; Kałuzny B; Kałuzny JJ
Klin Oczna; 2005; 107(1-3):70-2. PubMed ID: 16052806
[TBL] [Abstract][Full Text] [Related]
30. [Soluble thrombomodulin--a molecular marker of endothelial cell injury in children and adolescents with obesity].
Urban M; Wojtkielewicz K; Głowińska B; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):73-7. PubMed ID: 15996335
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor (PAI) in obese men and obese women.
Cucuianu M; Lanczek M; Roman S
Rom J Intern Med; 1993; 31(3):183-92. PubMed ID: 8130756
[TBL] [Abstract][Full Text] [Related]
32. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Nadar SK; Al Yemeni E; Blann AD; Lip GY
Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
[TBL] [Abstract][Full Text] [Related]
33. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
34. Haemostasis in patients with Behçet's disease.
Demirer S; Sengül N; Yerdel MA; Tüzüner A; Ulus AT; Gürler A; Bergqvist D; Siegbahn A; Karacagil S
Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):570-4. PubMed ID: 10873722
[TBL] [Abstract][Full Text] [Related]
35. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
[TBL] [Abstract][Full Text] [Related]
36. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
37. [Changes of relative variables about prethrombosis state and its clinical significance in patients with pregnancy induced hypertension].
Liu BY; Zhong M; Yu YH; Zheng L; Wang Q; Guo WL
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):85-8. PubMed ID: 12783694
[TBL] [Abstract][Full Text] [Related]
38. Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S.
Leitner GC; Schmetterer L; Kapiotis S; Jilma B
Thromb Res; 2010 Jan; 125(1):e5-8. PubMed ID: 19729191
[TBL] [Abstract][Full Text] [Related]
39. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator.
Takahashi H; Ito S; Hanano M; Wada K; Niwano H; Seki Y; Shibata A
Am J Hematol; 1992 Sep; 41(1):32-9. PubMed ID: 1323930
[TBL] [Abstract][Full Text] [Related]
40. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
